FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Brooks Low

Research Profile

Living Beings

Disorders

Chemicals & Drugs

Physiology

Procedures

Co-author Network

Publications

TOP 3
Verena Karsten; Sean R Murray; Jeremy Pike; Kimberly Troy; Martina Ittensohn; Manvel Kondradzhyan; K Brooks Low; David Bermudes
msbB deletion confers acute sensitivity to CO2 in Salmonella enterica serovar Typhimurium that can be suppressed by a loss-of-function mutation in zwf.
Sean R Murray; Robert Ernst; David Bermudes; Samuel I Miller; K Brooks Low
pmrA(Con) confers pmrHFIJKL-dependent EGTA and polymyxin resistance on msbB Salmonella by decorating lipid A with phosphoethanolamine.
Sean R Murray; Karim Suwwan de Felipe; Pamela L Obuchowski; Jeremy Pike; David Bermudes; K Brooks Low
Hot spot for a large deletion in the 18- to 19-centisome region confers a multiple phenotype in Salmonella enterica serovar Typhimurium strain ATCC 14028.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Brooks Low (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: Verena Karsten; Sean R Murray; Jeremy Pike; Kimberly Troy; Martina Ittensohn; Manvel Kondradzhyan; K Brooks Low; David Bermudes
msbB deletion confers acute sensitivity to CO2 in Salmonella enterica serovar Typhimurium that can be suppressed by a loss-of-function mutation in zwf.
BMC microbiology 2009;9():170.
2007: Sean R Murray; Robert Ernst; David Bermudes; Samuel I Miller; K Brooks Low
pmrA(Con) confers pmrHFIJKL-dependent EGTA and polymyxin resistance on msbB Salmonella by decorating lipid A with phosphoethanolamine.
Journal of bacteriology 2007;189(14):5161-9.
2004: Sean R Murray; Karim Suwwan de Felipe; Pamela L Obuchowski; Jeremy Pike; David Bermudes; K Brooks Low
Hot spot for a large deletion in the 18- to 19-centisome region confers a multiple phenotype in Salmonella enterica serovar Typhimurium strain ATCC 14028.
Journal of bacteriology 2004;186(24):8516-23.
2004: Benfang Ruan; Hiroaki Nakano; Masashi Tanaka; Jonathan A Mills; Joseph A DeVito; Bokkee Min; K Brooks Low; John R Battista; Dieter Söll
Cysteinyl-tRNA(Cys) formation in Methanocaldococcus jannaschii: the mechanism is still unknown.
Journal of bacteriology 2004;186(1):8-14.
2004: K Brooks Low; Martina Ittensohn; Xiang Luo; Li-mou Zheng; Ivan King; John Pawelek; David Bermudes
Construction of VNP20009: a novel, genetically stable antibiotic-sensitive strain of tumor-targeting Salmonella for parenteral administration in humans.
Methods in molecular medicine 2004;90():47-60.
2003: John Pawelek; K Brooks Low; David Bermudes
Bacteria as tumour-targeting vectors.
The lancet oncology 2003;4(9):548-56.
2002: John Pawelek; Stefano Sodi; Ashok K Chakraborty; James T Platt; Samuel Miller; David W Holden; Michael Hensel; K Brooks Low
Salmonella pathogenicity island-2 and anticancer activity in mice.
Cancer gene therapy 2002;9(10):813-8.
2001: Sean R Murray; David Bermudes; Karim Suwwan de Felipe; K Brooks Low
Extragenic suppressors of growth defects in msbB Salmonella.
Journal of bacteriology 2001;183(19):5554-61.
2001: David Bermudes; K Brooks Low; John Pawelek; M Feng; M Belcourt; Li-mou Zheng; Ivan King
Tumour-selective Salmonella-based cancer therapy.
Biotechnology & genetic engineering reviews 2001;18():219-33.
2000: J Platt; Stefano Sodi; M Kelley; S Rockwell; David Bermudes; K Brooks Low; John Pawelek
Antitumour effects of genetically engineered Salmonella in combination with radiation.
European journal of cancer (Oxford, England : 1990) 2000;36(18):2397-402.
2000: C Clairmont; King C Lee; Jeremy Pike; Martina Ittensohn; K Brooks Low; John Pawelek; David Bermudes; S M Brecher; D Margitich; J Turnier; Zujin Li; Xiang Luo; Ivan King; Li-mou Zheng
Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium.
The Journal of infectious diseases 2000;181(6):1996-2002.
1999: K Brooks Low; Martina Ittensohn; Trung Le; J Platt; Stefano Sodi; M Amoss; O Ash; E Carmichael; Ashok Chakraborty; J Fischer; SL Lin; Xiang Luo; S I Miller; L Zheng; Ivan King; John Pawelek; David Bermudes
Lipid A mutant Salmonella with suppressed virulence and TNFalpha induction retain tumor-targeting in vivo.
Nature biotechnology 1999;17(1):37-41.
1997: John Pawelek; K Brooks Low; David Bermudes
Tumor-targeted Salmonella as a novel anticancer vector.
Cancer research 1997;57(20):4537-44.
1997: Sung Kay Chiu; K Brooks Low; A Yuan; Charles M Radding
Resolution of an early RecA-recombination intermediate by a junction-specific endonuclease.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(12):6079-83.